TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
3,885.00
+165.00 (4.44%)
May 13, 2025, 3:30 PM KST
TELCON RF PHARMACEUTICAL. Revenue
In the year 2024, TELCON RF PHARMACEUTICAL. had annual revenue of 37.87B KRW with 4.29% growth. TELCON RF PHARMACEUTICAL. had revenue of 13.84B in the quarter ending December 31, 2024, with 7.07% growth.
Revenue
37.87B
Revenue Growth
+4.29%
P/S Ratio
1.23
Revenue / Employee
298.15M
Employees
127
Market Cap
46.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37.87B | 1.56B | 4.29% |
Dec 31, 2023 | 36.31B | 8.48B | 30.46% |
Dec 31, 2022 | 27.83B | -10.01B | -26.46% |
Dec 31, 2021 | 37.84B | 4.70B | 14.18% |
Dec 31, 2020 | 33.14B | -23.45B | -41.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.07T |
SK hynix | 71.40T |
SK Square | 6,138.47B |
LG Electronics | 89.37T |
LG Corp. | 7,175.51B |
Samsung SDS | 14.07T |
Samsung Electro-Mechanics | 10.29T |
HANMI Semiconductor | 558.92B |